NCT05480943

Brief Summary

Thiamine micronutrient deficiency (TD) can cause a variety of non-specific symptoms and leads to several thiamine deficiency disorders such as heart failure, polyneuropathy, Wernicke's Encephalopathy and generalized weakness and debility. Symptoms are often vague and non-specific such as fatigue, leg swelling, imbalance, confusion, mood disorders, gastrointestinal upset, and weakness. Hospitalized Veterans may be particularly susceptible to TD due to food insecurity and chronic illnesses which cause inflammation and increased metabolic demands. This study aims to determine the prevalence of TD in hospitalized Veterans which has never been done before. The investigators also seek to identify risk factors causing TD including acute and chronic forms of inflammation, food insecurity, and dietary habits. Lastly, the investigators hope to clarify the abnormally low levels of blood thiamine that correlate with symptoms of TD that improve with replenishment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
206

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 19, 2022

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

July 27, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 29, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
10 months until next milestone

Results Posted

Study results publicly available

October 15, 2025

Completed
Last Updated

January 29, 2026

Status Verified

January 1, 2026

Enrollment Period

2.2 years

First QC Date

July 27, 2022

Results QC Date

August 27, 2025

Last Update Submit

January 13, 2026

Conditions

Keywords

thiamine deficiencyWernicke's encephalopathyberiberideliriumpolyneuropathyvitamin B1falls

Outcome Measures

Primary Outcomes (1)

  • Percentage of Participants With Thiamine Deficiency (Low Plasma Thiamine) Out of Total Number of Enrolled Veterans With Plasma Thiamine Results

    The percentage of enrolled non-alcoholic veterans who have thiamine deficiency (defined as low plasma thiamine levels) out of the total number of enrolled Veterans with plasma thiamine results.

    Baseline

Secondary Outcomes (2)

  • Association of Thiamine Deficiency and Inflammation

    Baseline

  • Cut-point Analysis of Thiamine Biomarkers

    Baseline compared to follow up visit

Study Arms (1)

Hospitalized non-alcoholic Veterans

Any Veteran with full admission to the VA Sierra Nevada Healthcare System Hospital.

Dietary Supplement: Thiamine repletion

Interventions

Thiamine repletionDIETARY_SUPPLEMENT

If a participant is determined by clinical characteristics or biomarker results to be thiamine deficient, thiamine supplementation was provided.

Hospitalized non-alcoholic Veterans

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Veterans who are admitted to the medicine service at the VA Sierra Nevada Healthcare System hospital in Reno, NV who do not use alcohol to excess. The Veterans will need to live within 75 miles of the medical center to facilitate return for follow up appointments.

You may qualify if:

  • full admission to the hospital medical service (not on observation status)

You may not qualify if:

  • excess alcohol intake as defined by the National Institute of Alcohol Abuse and Alcoholism
  • taking thiamine supplement
  • quadriplegic
  • lives more than 75 miles from the medical center
  • unable to demonstrate capacity to understand the study and provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Sierra Nevada Health Care System, Reno, NV

Reno, Nevada, 89502-0993, United States

Location

Related Publications (6)

  • Mates E, Alluri D, Artis T, Riddle MS. A Retrospective Case Series of Thiamine Deficiency in Non-Alcoholic Hospitalized Veterans: An Important Cause of Delirium and Falling? J Clin Med. 2021 Apr 1;10(7):1449. doi: 10.3390/jcm10071449.

    PMID: 33916273BACKGROUND
  • Gomes F, Bergeron G, Bourassa MW, Fischer PR. Thiamine deficiency unrelated to alcohol consumption in high-income countries: a literature review. Ann N Y Acad Sci. 2021 Aug;1498(1):46-56. doi: 10.1111/nyas.14569. Epub 2021 Feb 11.

    PMID: 33576090BACKGROUND
  • Donnino MW, Carney E, Cocchi MN, Barbash I, Chase M, Joyce N, Chou PP, Ngo L. Thiamine deficiency in critically ill patients with sepsis. J Crit Care. 2010 Dec;25(4):576-81. doi: 10.1016/j.jcrc.2010.03.003. Epub 2010 Jun 19.

    PMID: 20646908BACKGROUND
  • Whitfield KC, Bourassa MW, Adamolekun B, Bergeron G, Bettendorff L, Brown KH, Cox L, Fattal-Valevski A, Fischer PR, Frank EL, Hiffler L, Hlaing LM, Jefferds ME, Kapner H, Kounnavong S, Mousavi MPS, Roth DE, Tsaloglou MN, Wieringa F, Combs GF Jr. Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs. Ann N Y Acad Sci. 2018 Oct;1430(1):3-43. doi: 10.1111/nyas.13919. Epub 2018 Aug 27.

    PMID: 30151974BACKGROUND
  • Lee DC, Chu J, Satz W, Silbergleit R. Low plasma thiamine levels in elder patients admitted through the emergency department. Acad Emerg Med. 2000 Oct;7(10):1156-9. doi: 10.1111/j.1553-2712.2000.tb01268.x.

    PMID: 11015250BACKGROUND
  • Smith TJ, Johnson CR, Koshy R, Hess SY, Qureshi UA, Mynak ML, Fischer PR. Thiamine deficiency disorders: a clinical perspective. Ann N Y Acad Sci. 2021 Aug;1498(1):9-28. doi: 10.1111/nyas.14536. Epub 2020 Dec 10.

    PMID: 33305487BACKGROUND

Biospecimen

Retention: NONE RETAINED

No specimen will be retained.

MeSH Terms

Conditions

Thiamine DeficiencyWernicke EncephalopathyBeriberiDeliriumPolyneuropathies

Condition Hierarchy (Ancestors)

Vitamin B DeficiencyAvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic DiseasesBrain Diseases, MetabolicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMetabolic DiseasesAlcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental DisordersConfusionNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersPeripheral Nervous System DiseasesNeuromuscular Diseases

Limitations and Caveats

Multiple prolonged work stoppages due to unforeseen events led to lower than expected enrollment. Poor compliance with follow up visits after initial evaluation in the hospital.

Results Point of Contact

Title
Elisabeth Mates, MD,PhD, Principal investigator
Organization
VA Sierra Nevada Healthcare System

Study Officials

  • Elisabeth A Mates, MD PhD

    VA Sierra Nevada Health Care System, Reno, NV

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 27, 2022

First Posted

July 29, 2022

Study Start

July 19, 2022

Primary Completion

September 30, 2024

Study Completion

December 30, 2024

Last Updated

January 29, 2026

Results First Posted

October 15, 2025

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Deidentified data set will be shared upon request made to Dr. Elisabeth Mates

Locations